Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Acute Aluminum Phosphide Poisoning
NCT07916922Phase 3Recruiting
- Sponsor
- Ain Shams University
- Start
- May 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of trimetazidine in aluminum phosphide poisoning, sponsored by Ain Shams University. Started May 2026; status: recruiting.
02
Drugs
trimetazidine
03
Conditions
aluminum phosphide poisoning
Beyond the preview
Go deeper on NCT07916922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916922.